12,559 Shares in CME Group Inc. (NASDAQ:CME) Purchased by Claro Advisors LLC

Claro Advisors LLC purchased a new stake in CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 12,559 shares of the financial services provider’s stock, valued at approximately $2,771,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Oak Harvest Investment Services grew its stake in shares of CME Group by 66.5% in the first quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after buying an additional 18,017 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of CME Group by 21.2% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after purchasing an additional 8,443 shares during the period. Duality Advisers LP acquired a new position in shares of CME Group in the first quarter valued at approximately $1,455,000. SG Americas Securities LLC increased its stake in CME Group by 312.2% during the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock worth $12,222,000 after buying an additional 42,996 shares during the period. Finally, Cetera Investment Advisers increased its position in shares of CME Group by 429.1% during the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after acquiring an additional 38,540 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft boosted their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Morgan Stanley boosted their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday. TD Cowen started coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective on the stock. Barclays lifted their price objective on shares of CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a research report on Monday, October 7th. Finally, JPMorgan Chase & Co. increased their target price on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $220.07.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Price Performance

CME Group stock traded up $0.43 during trading hours on Friday, hitting $227.66. The stock had a trading volume of 181,214 shares, compared to its average volume of 1,936,762. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.12. The stock has a market capitalization of $81.97 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 7.76 and a beta of 0.55. The stock’s fifty day moving average is $216.48 and its two-hundred day moving average is $208.28. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the prior year, the firm posted $2.30 earnings per share. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. As a group, analysts predict that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.